Literature DB >> 6128962

The surgical management of medullary thyroid carcinoma.

C F Russell, J A Van Heerden, G W Sizemore, A J Edis, W F Taylor, W H ReMine, J A Carney.   

Abstract

Medullary carcinoma of the thyroid may occur in three patient groups: multiple endocrine neoplasia, type 2b (MEN2b), MEN2a, and sporadic. The prognosis is best in MEN2a and worst in MEN2b. Multicentric disease occurs in approximately 90% of patients in the MEN groups and in 20% of the patients in the sporadic group. The minimal surgical procedure advocated is total thyroidectomy with dissection of the central compartment nodes. When neck dissection is performed, there appears to be no advantage in resecting the internal jugular vein or the sternomastoid muscle. Primary relatives of all patients with medullary carcinoma should be screened by measurement of plasma immunoreactive calcitonin to identify C-cell disease in a generally unsuspecting group/reservoir and because it results in earlier diagnosis, which leads to a less extensive surgical procedure and a higher percentage of patients with a disease-free state.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6128962      PMCID: PMC1352852     

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  Stimulation tests for diagnosis of medullary thyroid carcinoma.

Authors:  G W Sizemore; V L Go
Journal:  Mayo Clin Proc       Date:  1975-02       Impact factor: 7.616

2.  Plasma calcitonin in normal man. Differences between men and women.

Authors:  H Heath; G W Sizemore
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

3.  Multiple endocrine neoplasia type IIb: the most aggressive form of medullary thyroid carcinoma.

Authors:  J A Norton; L C Froome; R E Farrell; S A Wells
Journal:  Surg Clin North Am       Date:  1979-02       Impact factor: 2.741

4.  A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary carcinoma of the thyroid.

Authors:  J F Hennessy; S A Wells; D A Ontjes; C W Cooper
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

5.  Relations of calcitonin and gastrin in the Zollinger-Ellison syndrome and medullary carcinoma of the thyroid.

Authors:  G W Sizemore; V L Go; E L Kaplan; L J Sanzenbacher; K H Holtermuller; C D Arnaud
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245

6.  Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in 2 patients with medullary carcinoma of the thyroid.

Authors:  J F Hennessy; T K Gray; C W Cooper; D A Ontjes
Journal:  J Clin Endocrinol Metab       Date:  1973-01       Impact factor: 5.958

7.  Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay.

Authors:  K E Melvin; H H Miller; A H Tashjian
Journal:  N Engl J Med       Date:  1971-11       Impact factor: 91.245

8.  Familial medullary carcinoma of the thyroid.

Authors:  M A Block; R C Horn; J M Miller; J L Barrett; B E Brush
Journal:  Ann Surg       Date:  1967-09       Impact factor: 12.969

Review 9.  C-cell disease of the thyroid gland in multiple endocrine neoplasia, type 2b.

Authors:  J A Carney; G W Sizemore; A V Hayles
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

Review 10.  Biologic markers in cancer diagnosis and treatment.

Authors:  E D Holyoke; G E Block; E Jensen; G W Sizemore; H Heath; T M Chu; G P Murphy; A Mittelman; R W Ruddon; M S Arnott
Journal:  Curr Probl Cancer       Date:  1981-08       Impact factor: 3.187

View more
  18 in total

1.  Prognostic factors for sporadic medullary thyroid carcinoma.

Authors:  Kaptan Gülben; Uğur Berberoğlu; Mustafa Boyabatli
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

Review 2.  Multiple endocrine neoplasia.

Authors:  R A Decker; S A Wells
Journal:  Jpn J Surg       Date:  1989-11

3.  Medullary thyroid carcinoma in Northern Ireland, 1967-1997.

Authors:  S J Dolan; C F Russell
Journal:  Ann R Coll Surg Engl       Date:  2000-05       Impact factor: 1.891

4.  Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma.

Authors:  J A van Heerden; C S Grant; H Gharib; I D Hay; D M Ilstrup
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

5.  Total parenteral nutrition with F080 in cirrhotics with subclinical encephalopathy.

Authors:  W J Millikan; J M Henderson; W D Warren; S P Riepe; M H Kutner; L Wright-Bacon; C Epstein; R B Parks
Journal:  Ann Surg       Date:  1983-03       Impact factor: 12.969

6.  Prognostic value of nuclear DNA content in medullary thyroid carcinoma.

Authors:  M Bäckdahl; E Tallroth; G Auer; G Forsslund; P O Granberg; G Lundell; T Löwhagen
Journal:  World J Surg       Date:  1985-12       Impact factor: 3.352

7.  [Radicality principles in operations on malignant thyroid tumors].

Authors:  R A Wahl; P E Goretzki; K Joseph; H D Röher
Journal:  Langenbecks Arch Chir       Date:  1985

8.  Markov model-based estimation of individual survival probability for medullary thyroid cancer patients.

Authors:  Olga Esik; Gábor Tusnády; Lajos Trón; András Boér; Zoltán Szentirmay; István Szabolcs; Károly Rácz; Erzsébet Lengyel; Judit Székely; Miklós Kásler
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

9.  [Progress in the diagnosis and therapy of C cell carcinoma of the thyroid gland].

Authors:  A Frilling; P E Goretzki; H D Röher
Journal:  Langenbecks Arch Chir       Date:  1990

10.  Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma.

Authors:  H Dralle; I Damm; G F Scheumann; J Kotzerke; E Kupsch; H Geerlings; R Pichlmayr
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.